Enanta Pharmaceuticals, Inc
€11.35
EUR
Last updated on --.
24h volume295.43K
24h highest11.9096 EUR
24h lowest11.2604 EUR
24h Price movement-2.44%
ENTA recent prices
24 Hours
-2.44%-€0.28377
30 days
-1.89%-€0.22271
60 days
+10.44%+€1.092
90 days
-5.94%-€0.73006
Key data
Previous close11.6344 EUR
Market cap340.31M EUR
Volume295.43K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.8316 EUR
Net income (FY)-53.30M EUR
Revenue (FY)59.52M EUR
Last report dateMay 13, 2026
About Enanta Pharmaceuticals, Inc
HeadquartersWATERTOWN
Employees (FY)120.00
Revenue per employee (FY)495.97K EUR
Net income per employee (FY)-444.17K EUR
Listed onNasdaq
ENTA conversion tables
 |  |
|---|---|
| 0.5 ENTA | 5.675 EUR |
| 1 ENTA | 11.35 EUR |
| 5 ENTA | 56.75 EUR |
| 10 ENTA | 113.5 EUR |
| |
|---|---|
| 0.5 EUR | 0.04405 ENTA |
| 1 EUR | 0.0881 ENTA |
| 5 EUR | 0.4405 ENTA |
| 10 EUR | 0.881 ENTA |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ENTA is trading at €11.35, -2.44% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ENTA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ENTA is currently trading at €11.35, -2.44% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ENTA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ENTA's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ENTA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ENTA's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Enanta Pharmaceuticals, Inc's market cap is currently 340.31M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume295.43K
24h highest11.9096 EUR
24h lowest11.2604 EUR
24h Price movement-2.44%
Start trade with ENTA Perpetual
Sign up to trade